The blocking of kappa‐opioid receptor reverses the changes in dorsolateral striatum dopamine dynamics during the amphetamine sensitization - Azocar - 2019 - Journal of Neurochemistry - Wiley Online Library
Antagonist for the Kappa Opioid Receptor - Probe Reports from the NIH Molecular Libraries Program - NCBI Bookshelf
Major Depressive Disorder and Kappa Opioid Receptor
Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses | ACS Chemical Neuroscience
Medicinal Chemistry of Kappa Opioid Receptor Antagonists | SpringerLink
Agonist-induced phosphorylation bar code and differential post-activation signaling of the delta opioid receptor revealed by phosphosite-specific antibodies | Scientific Reports
An Improved Antagonist Radiotracer for the κ-Opioid Receptor: Synthesis and Characterization of 11C-LY2459989 | Journal of Nuclear Medicine
Kappa‐Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials - Carlezon - 2016 - Depression and Anxiety - Wiley Online Library
Opioids to Treat Depression: The Jury Is Out
Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders | SpringerLink
Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor | Journal of Medicinal Chemistry
Frontiers | The Role of the Kappa Opioid System in Comorbid Pain and Psychiatric Disorders: Function and Implications
A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse - ScienceDirect
Kappa opioid receptor antagonism: Are opioids the answer for treatment resistant depression?
Antagonists of the kappa opioid receptor - ScienceDirect
Effects of a Post-Shock Injection of the Kappa Opioid Receptor Antagonist Norbinaltorphimine (norBNI) on Fear and Anxiety in Rats | PLOS ONE
Major Depressive Disorder and Kappa Opioid Receptor
Frontiers Publishing Partnerships | Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine
Frontiers | Crosstalk Between Kappa Opioid and Dopamine Systems in Compulsive Behaviors